Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00723333 · ClinicalTrials.gov registry record
Bone Marrow Transplant Chart Review for RIC
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 30
- Enrollment target
NCT00723333: Completed study, sponsored by University of Utah.
NCT00723333 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00723333 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
We will evaluate the records of 30 patients that have undergone allogeneic transplant, specifically looking at engraftment rate, relapse rate, disease free survival, overall survival, causes of death and other pertinent statistics. We will compare the outcomes to appropriate historical controls.
Interventions
- PROCEDURE Reduced Intensity Conditioning (RIC) Allogenic Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-07 |
What the finished NCT00723333 record still lists
NCT00723333 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Reduced Intensity Conditioning (RIC) Allogenic Transplant is the first listed.
NCT00723333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00723333 about?
NCT00723333 is a clinical study titled "Bone Marrow Transplant Chart Review for RIC". We will evaluate the records of 30 patients that have undergone allogeneic transplant, specifically looking at engraftment rate, relapse rate, disease free survival, overall survival, causes of death and other pertinent statistics. We will compare the outcomes to appropriate historical controls.
What is the current status of trial NCT00723333?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2008-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00723333?
The interventions under investigation include: Reduced Intensity Conditioning (RIC) Allogenic Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00723333?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia